Adult bronchiolitis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
The incidence for adult bronchiolitis is not well recorded, it is estimated that in the USA 2 - 5% of all community acquired pneumonias have underlying bronchiolitis.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 


===Prevalence===
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*The prevalence of adult-onset bronchiolitis is unknown.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The most common cause of bronchiolitis in adults is RSV, most adults tend to be asymptomatic or carriers and therefore, prevalence is difficult to stipulate.  
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
The attack rate for death caused by bronchiolitis complicated by pneumonia in elderly homes is approximately 2 - 5%.  
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
===Age===
*Patients of all age groups may develop [disease name].
The incidence of adult bronchiolitis increases with age; the median age at diagnosis is 68 years.
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
 
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
There is no racial predilection in adults.  
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 
===Gender===
===Gender===
*[Disease name] affects men and women equally.
Men are more commonly affected by bronchiolitis than women, and tend to have higher mortality rates.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
===Region===
===Region===
*The majority of [disease name] cases are reported in [geographical region].
*Diffuse panbronchiolitis is a common disease that tends to affect Japan.
 
*Those of Hispanic, Native American and Alaskan origins tend to have a higher likelihood of hospitalization.
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].


===Developed Countries===
===Developed Countries vs. Developing Countries===
Developed and developing countries tend to have similar incidence, hospitalisation and mortality rates.


===Developing Countries===





Revision as of 16:27, 27 February 2018

Adult bronchiolitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Occupational lung disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adult bronchiolitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adult bronchiolitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adult bronchiolitis epidemiology and demographics

CDC on Adult bronchiolitis epidemiology and demographics

Adult bronchiolitis epidemiology and demographics in the news

Blogs on Adult bronchiolitis epidemiology and demographics


Risk calculators and risk factors for Adult bronchiolitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Epidemiology and Demographics

Incidence

The incidence for adult bronchiolitis is not well recorded, it is estimated that in the USA 2 - 5% of all community acquired pneumonias have underlying bronchiolitis.


Prevalence

  • The prevalence of adult-onset bronchiolitis is unknown.
  • The most common cause of bronchiolitis in adults is RSV, most adults tend to be asymptomatic or carriers and therefore, prevalence is difficult to stipulate.

Case-fatality rate/Mortality rate

The attack rate for death caused by bronchiolitis complicated by pneumonia in elderly homes is approximately 2 - 5%.

Age

The incidence of adult bronchiolitis increases with age; the median age at diagnosis is 68 years.


Race

There is no racial predilection in adults.

Gender

Men are more commonly affected by bronchiolitis than women, and tend to have higher mortality rates.

Region

  • Diffuse panbronchiolitis is a common disease that tends to affect Japan.
  • Those of Hispanic, Native American and Alaskan origins tend to have a higher likelihood of hospitalization.

Developed Countries vs. Developing Countries

Developed and developing countries tend to have similar incidence, hospitalisation and mortality rates.


References